Adicet Bio, Inc. (ACET) vs Hyperion DeFi, Inc. (HYPD)
- Adicet Bio, Inc. ACET 4.57 −11.09%
- Hyperion DeFi, Inc. HYPD 2.84 −9.84%
Adicet Bio, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Adicet Bio, Inc. and Hyperion DeFi, Inc. are of similar size ($49.0M and $48.1M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against 224.6%. Adicet Bio, Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (−2,518.2% vs 2.73%). Across the 18 metrics below, Hyperion DeFi, Inc. leads on 10 and Adicet Bio, Inc. on 8.
Valuation
Profitability
| Metric | ACET | HYPD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 78.35% | 65.16% |
| Operating margin | 0.00% | 314.32% | 0.00% |
| Net margin | 0.00% | (1,224.53%) | 0.00% |
| Free cash flow margin | 0.00% | (5,509.35%) | 0.00% |
| Return on equity | (78.08%) | (24.63%) | (56.36%) |
| Return on assets | (63.62%) | (20.32%) | (48.04%) |
| Return on invested capital | (2,518.16%) | 2.73% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack